A weekly conversation with the innovators who will change how health care is delivered.
Scott Whitaker, the CEO of AdvaMed, has worked in DC for close to two decades. So naturally, we asked him for his take on what the outcome of the midterm elections means for Medtech. Does it improve…
Jim Dillon, president and CEO of Renal Guard, talks about the company’s decision to create Reprieve Cardiovascular, a start-up focusing on heart failure. Reprieve raised $7 million from outside inves…